Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease Evidence Review and Practical Considerations

被引:10
|
作者
Copeland, Carla R. [1 ]
Collins, Bridget F. [2 ]
Salisbury, Margaret L. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37235 USA
[2] Univ Washington, Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
environmental lung disease; hypersensitivity pneumonitis; pulmonary fibrosis; IDIOPATHIC PULMONARY-FIBROSIS; OCCUPATIONAL HYPERSENSITIVITY PNEUMONITIS; ASTHMA MORBIDITY; FARMERS LUNG; RISK-FACTORS; CIGARETTE-SMOKING; PROTECTIVE VALUE; MULTI-TRIGGER; ANTIGEN; METAL;
D O I
10.1016/j.chest.2021.02.021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A relationship between inhalational exposure to materials in the environment and development of interstitial lung disease (ILD) is long recognized. Hypersensitivity pneumonitis is an environmentally -induced diffuse parenchymal lung disease. In addition to hypersensitivity pneumonitis, domestic and occupational exposures have been shown to influence onset and progression of other ILDs, including idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis. A key component of the clinical evaluation of patients presenting with ILD includes elucidation of a complete exposure history, which may influence diagnostic classification of the ILD as well as its management. Currently, there is no standardized approach to environmental evaluation or remediation of potentially harmful exposures in home or workplace environments for patients with ILD. This review discusses evidence for environmental contributions to ILD pathogenesis and draws on asthma and occupational medicine literature to frame the potential utility of a professional evaluation for environmental factors contributing to the development and progression of ILD. Although several reports suggest benefits of environmental assessment for those with asthma or certain occupational exposures, lack of information about benefits in broader populations may limit application. Determining the feasibility, long-term outcomes, and cost-effectiveness of environmental evaluation and remediation in acute and chronic ILDs should be a focus of future research.
引用
收藏
页码:219 / 230
页数:12
相关论文
共 50 条
  • [21] The Spectrum of Progressive Fibrosing Interstitial Lung Disease: Clinical and Managed Care Considerations
    Hamblin, Mark J.
    Kaner, Robert J.
    Owens, Gary M.
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (07) : S147 - S154
  • [22] Interstitial Lung Disease in Giant Cell Arteritis Review of 23 Patients
    Kimbrough, Bradly A.
    Baqir, Misbah
    Johnson, Tucker F.
    Vasireddy, Amit
    Ryu, Jay H.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E3 - E8
  • [23] Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
    Dsouza, Kevin G.
    Alexander, Amanda S.
    Watts Jr, Jubal R.
    Kulkarni, Tejaswini
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2023, 18
  • [24] Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations
    Shao, Tihong
    Shi, Xiaodong
    Yang, Shanpeng
    Zhang, Wei
    Li, Xiaohu
    Shu, Jingwei
    Alqalyoobi, Shehabaldin
    Zeki, Amir A.
    Leung, Patrick S.
    Shuai, Zongwen
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] Screening of interstitial lung disease in patients with rheumatoid arthritis: A systematic review
    Garrote-Corral, Sandra
    Silva-Fernandez, Lucia
    Seoane-Mato, Daniel
    Guerra-Rodriguez, Mercedes
    Aburto, Myriam
    Castaneda, Santos
    Valenzuela, Claudia
    Narvaez, Javier
    REUMATOLOGIA CLINICA, 2022, 18 (10): : 587 - 596
  • [26] Supplemental Oxygen Therapy in Interstitial Lung Disease A Narrative Review
    Clark, Kristopher P.
    Degenholtz, Howard B.
    Lindell, Kathleen O.
    Kass, Daniel J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (11) : 1541 - 1549
  • [27] Scoping review of exposure questionnaires and surveys in interstitial lung disease
    Barnes, Hayley
    Elmrayed, Seham
    Barber, Christopher Michael
    Feary, Johanna
    Lee, Cathryn T.
    Gandhi, Sheiphali
    Peters, Cheryl E.
    Salisbury, Margaret L.
    Johannson, Kerri A.
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [28] Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
    Kobayashi, Haruki
    Naito, Tateaki
    Omae, Katsuhiro
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Murakami, Haruyasu
    Endo, Masahiro
    Harada, Hideyuki
    Takahashi, Toshiaki
    JOURNAL OF CANCER, 2018, 9 (11): : 2054 - 2060
  • [29] Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes
    Sun, Kelly
    Fisher, Jolene H.
    Pagnoux, Christian
    CURRENT RHEUMATOLOGY REPORTS, 2022, 24 (08) : 259 - 267
  • [30] Childhood Interstitial Lung Disease: A Systematic Review
    Hime, Neil J.
    Zurynski, Yvonne
    Fitzgerald, Dominic
    Selvadurai, Hiran
    Phu, Amy
    Deverell, Marie
    Elliott, Elizabeth J.
    Jaffe, Adam
    PEDIATRIC PULMONOLOGY, 2015, 50 (12) : 1383 - 1392